| 000 | 01147cam a2200217 4500500 | ||
|---|---|---|---|
| 005 | 20250121093628.0 | ||
| 041 | _afre | ||
| 042 | _adc | ||
| 100 | 1 | 0 |
_aFrances, Pierre _eauthor |
| 700 | 1 | 0 |
_a Gaubert, Robert _eauthor |
| 700 | 1 | 0 |
_a Gallaf, Widad _eauthor |
| 700 | 1 | 0 |
_a Merikhi, Adam _eauthor |
| 700 | 1 | 0 |
_a Noire, Marie Dorothée _eauthor |
| 700 | 1 | 0 |
_a Philipon, Emma _eauthor |
| 245 | 0 | 0 | _aNefopam in primary care: How can it be used and under which conditions? |
| 260 | _c2022. | ||
| 500 | _a22 | ||
| 520 | _aNefopam (Acupan®) is a centrally acting non-opioid analgesic used for the treatment of moderate to severe pain. Similar to a step one analgesic, according to the WHO pain ladder classification, it is a first- or second-line drug, depending on the intensity of the pain. However, due to a significant risk of drug dependence, it should not be used in the context of chronic pain. How can nefopam be used in primary care and under which conditions? | ||
| 786 | 0 | _nMédecine | 18 | 9 | 2022-11-01 | p. 395-397 | 1777-2044 | |
| 856 | 4 | 1 | _uhttps://shs.cairn.info/journal-medecine-2022-9-page-395?lang=en&redirect-ssocas=7080 |
| 999 |
_c516382 _d516382 |
||